Literature DB >> 2066224

Demographic, social and clinical correlates of Raynaud phenomenon.

J E Keil1, H R Maricq, M C Weinrich, A R McGregor, F Diat.   

Abstract

Our study has identified the demographic, social and clinical correlates of primary Raynaud phenomenon (RP) from a case-control study involving 235 subjects who were identified from a population-based prevalence survey of RP. All potential cases and a sampling of probable non-cases, identified by a screening questionnaire, were invited to a medical clinic for diagnostic testing and assignment of case or control status. Odds ratios (OR) for risk indicators for primary RP were estimated using multiple logistic regression to obtain 95% confidence intervals. The regression yielded statistically significant (p less than 0.05) positive associations for sex (OR = 3.0 for females versus males), self-reported alcohol use (OR = 1.1) and diastolic blood pressure (OR = 1.2) in those on antihypertensive medication. A significant (p = less than 0.01, OR = 0.4) negative association was found for Quetelet index (a measure of obesity). Near-significant or suggestive but non-significant negative associations were found between RP and marital status (p = 0.05, OR = 2.5), increased years of education and, for those on antihypertensive medication, higher systolic blood pressure (both p = 0.07).

Entities:  

Mesh:

Year:  1991        PMID: 2066224     DOI: 10.1093/ije/20.1.221

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  9 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Prevalence of Raynaud's phenomenon in a healthy Greek population.

Authors:  P V Voulgari; Y Alamanos; D Papazisi; K Christou; C Papanikolaou; A A Drosos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study).

Authors:  Whan-Seok Choi; Chang-Jin Choi; Kyung-Soo Kim; Jae-Ho Lee; Chan-Hee Song; Ju-Hye Chung; Sun-Myeoung Ock; Jung-Bok Lee; Chul-Min Kim
Journal:  Clin Rheumatol       Date:  2009-01-22       Impact factor: 2.980

Review 4.  Raynaud's phenomenon (primary).

Authors:  Janet Pope
Journal:  BMJ Clin Evid       Date:  2013-10-10

5.  Raynaud's phenomenon in Northern Sweden: a population-based nested case-control study.

Authors:  Albin Stjernbrandt; Hans Pettersson; Ingrid Liljelind; Tohr Nilsson; Jens Wahlström
Journal:  Rheumatol Int       Date:  2018-08-20       Impact factor: 2.631

Review 6.  Raynaud's phenomenon (primary).

Authors:  Janet Elizabeth Pope
Journal:  BMJ Clin Evid       Date:  2011-03-14

Review 7.  Raynaud's phenomenon (primary).

Authors:  Janet Elizabeth Pope
Journal:  BMJ Clin Evid       Date:  2008-12-16

Review 8.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies.

Authors:  Rozeena Garner; Rakesh Kumari; Peter Lanyon; Michael Doherty; Weiya Zhang
Journal:  BMJ Open       Date:  2015-03-16       Impact factor: 2.692

Review 9.  Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.

Authors:  Iqra Nawaz; Yashfa Nawaz; Eisha Nawaz; Muhammad Romail Manan; Adil Mahmood
Journal:  Cureus       Date:  2022-01-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.